Ryoko Motonaga

High Prevalence of Diabetes in Patients With Primary Aldosteronism (PA) Associated With Subclinical Hypercortisolism and Prediabetes More Prevalent in Bilateral Than Unilateral PA: A Large, Multicenter Cohort Study in Japan

Yuko Akehi, Toshihiko Yanase, Ryoko Motonaga et al. · Diabetes Care · 2019 · 93 citations

SGLT2 inhibitor ipragliflozin attenuates breast cancer cell proliferation

Shiho Komatsu, Takashi Nomiyama, Tomohiro Numata et al. · Endocrine Journal · 2019 · 81 citations · Full text

Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice

Hiroyuki Takahashi, Takashi Nomiyama, Yuichi Terawaki et al. · Biochemistry and Biophysics Reports · 2019 · 47 citations · Full text

Prescription of oral hypoglycemic agents for patients with type 2 diabetes mellitus: A retrospective cohort study using a Japanese hospital database

Makito Tanabe, Ryoko Motonaga, Yuichi Terawaki et al. · Journal of Diabetes Investigation · 2016 · 46 citations · Full text

Combined Treatment with Exendin-4 and Metformin Attenuates Prostate Cancer Growth

Yoko Tsutsumi, Takashi Nomiyama, Takako Kawanami et al. · PLoS ONE · 2015 · 43 citations · Full text